# Crispr Therapeutics (CRSP): value investors who own it

1 value investor held Crispr Therapeutics in their Q3 2026 13F, led by Horizon Kinetics. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Horizon Kinetics | 0.0% | $510k | Trimmed -4.5% | 26 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-19 | Kulkarni Samarth | Chief Executive Officer | Sold | 47837 | $2.4m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/crsp). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.